The CDTI Innovation invests, together with NARA HEALTH CAPITAL, in ULTRASOUND-INNOVATION MEDTECH, startup that develops a part of the medical diagnostic distinction in real-time childbirth pretérmino a real threat and a false

Ultrasound-Innovation Medtech, S.L. (INNITIUS), is a start-up born of research projects of the university of Granada and Andalusian service. It is currently developing a part of the medical diagnosis, FINEBIRHT, which makes it possible in real time, to distinguish between an event of childbirth pretérmino true and false threat of premature, using a combination between the waves twisting and artificial intelligence. Fine Birth consists of a probe into part to play a wave tube spreading harmless for the fabric, to analyse the response of extracting as parameter consistency of the fabric of the cervix. This parameter is introduced in its own software that incorporates an artificial intelligence algorithm to obtaining the final analysis.

In short, to evaluate INNITIUS patients with symptoms to decide if you need to be hospitalized and treated or not, thus optimizing resources for the health system and reducing the impact that the supply of drugs may have on patients pregnant women and their newborns.

NARA HEALTH CAPITAL (RCF)

Nara Capitalmanagement is a private capital, devoted to processing investment in biotech and digital health, and in initial stages of development.

It is in being deeply apalanca sectoral specialization to support startups that generate long-term value their investors and create a positive impact, improving the health and quality of life of patients and of society.

CDTI Innovation

The CDTI innovation is the agency of the ministry of science and innovation that supports innovation based on knowledge, advice and providing public funding for innovation through subsidies or aid partly refundable for innovation and managing public procurement, pre-commercial.

Additionally, through the initiative Innvierte Sustainable Economy, supports and facilitates the capitalization of technology companies. To date, the CDTI, through Innvierte, has committed more than 390 M €in 20 investment vehicles that have invested in more than 240 companies, and through its joint investment line directly committed an amount exceeding 300 M €in more than 120 companies. ”

The CDTI Innovation also facilitates the internationalization of business projects of r & D and innovation of spanish companies and entities and manages the participation of spanish companies in international r & D, Horizon and Eureka, Europe and in industries of science and space.

The centre for technological development and innovation, E.P.E. (CDTI) is a public entity under the ministry of Science and innovation.

More information:

Office of the press
prensa@cdti.es
91-581.55.00

On The Internet
Website:www.cdti.es
In Linkedin:https :// www.linkedin.com/company/29815
On Twitter:https :// twitter.com/CDTI _ innovation
On Youtube:https :// www.youtube.com/user/CDTIoficial